Clare E. Weeden
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Fibroblast Growth Factor Research 4
- Oncology 8
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Marie-Liesse Asselin-Labat (9 shared papers)Shelley Gorman (5 shared papers)Prue H. Hart (5 shared papers)Charles Swanton (5 shared papers)William Hill (3 shared papers)Emilia L. Lim (2 shared papers)Benjamin Solomon (2 shared papers)Eva Grönroos (1 shared paper)
- Journals
- PLoS ONE (3 papers)Cell Death and Differentiation (2 papers)Translational Lung Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Cell Metabolism (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Clare E. Weeden
24 papers receiving 699 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 132
- Oncology 199
- Immunology 136
- Pathology and Forensic Medicine 111
- Pulmonary and Respiratory Medicine 148
Countries citing papers authored by Clare E. Weeden
This map shows the geographic impact of Clare E. Weeden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare E. Weeden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare E. Weeden more than expected).
Fields of papers citing papers by Clare E. Weeden
This network shows the impact of papers produced by Clare E. Weeden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare E. Weeden. The network helps show where Clare E. Weeden may publish in the future.
Co-authors
The 25 scholars most cited alongside Clare E. Weeden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 115 | |
| 2 | 2018 | 72 | |
| 3 | 2023 | 61 | |
| 4 | 2021 | 56 | |
| 5 | 2013 | 50 | |
| 6 | 2012 | 48 | |
| 7 | 2017 | 40 | |
| 8 | 2015 | 35 | |
| 9 | 2017 | 31 | |
| 10 | 2022 | 30 | |
| 11 | 2015 | 26 | |
| 12 | 2016 | 24 | |
| 13 | 2012 | 23 | |
| 14 | 2017 | 19 | |
| 15 | 2016 | 19 | |
| 16 | 2018 | 13 | |
| 17 | 2023 | 10 | |
| 18 | 2021 | 10 | |
| 19 | 2022 | 10 | |
| 20 | 2024 | 9 |
About Clare E. Weeden
Clare E. Weeden is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 24 papers that have together received 709 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Cancer Cells and Metastasis (4 papers), Vitamin D Research Studies (4 papers), Fibroblast Growth Factor Research (4 papers), Genetic factors in colorectal cancer (3 papers), Asthma and respiratory diseases (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Cancer Research (132 citations), Oncology (199 citations), Immunology (136 citations), Pathology and Forensic Medicine (111 citations) and Pulmonary and Respiratory Medicine (148 citations). Clare E. Weeden has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Marie-Liesse Asselin-Labat, Shelley Gorman, Prue H. Hart, Charles Swanton, William Hill, Emilia L. Lim, Benjamin Solomon, Eva Grönroos, Naomi M. Scott and Aliaksei Z. Holik. Their work appears in journals such as PLoS ONE, Cell Death and Differentiation, Translational Lung Cancer Research, Molecular Cancer Therapeutics and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.